The US Preventive Services Task Force (USPSTF) has recommended against routine prostate-specific antigen (PSA)–based prostate cancer (PCa) screening, initially for men older than 75 years in 2008, and then for all men in 2012. The gene discussed is KLK3; the disease is prostate carcinoma.